Showing 101-120 of 176 for: EBMG evidence summaries > Oncology 
- Olanzapine alone or in combination for acute mania
EBMG evidence summaries, 19-Feb-2004
Olanzapine is an effective treatment for mania and may be more efficacious than divalproex, though leads to more weight gain.
- Oprelvekin in chemotherapy-induced thrombocytopenia
EBMG evidence summaries, 8-Aug-2003
Oprelvekin may accelerate platelet recovery and reduce the need for platelet transfusion in chemotherapy-induced thrombocytopenia.
- Oral anticoagulation for prolonging survival in patients with cancer
EBMG evidence summaries, 22-Aug-2007
Oral anticoagulation is not effective for prolonging survival in patients with cancer. It appears to reduce mortality in the subgroup of small cell lung cancer patients at six months but not at one year.
- Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy
EBMG evidence summaries, 7-Jan-2010
Oral pilocarpine appears to alleviate the symptoms of radiation-induced salivary gland dysfunction. Adverse effects appears to be dose dependent.
- Outreach-based HIV prevention for injecting drug users
EBMG evidence summaries, 11-Aug-2003
Outreach-based interventions may be effective in inducing behaviour change in injecting drug users.
- Palliative radiotherapy regimes for non-small cell lung cancer
EBMG evidence summaries, 21-Dec-2006
No particular radiotherapy regimen appears to provide greater palliation than others for symptoms of patients with non-small cell lung cancer. Patients with better performance status may benefit from the use of high dose palliative regimes.
- Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS
EBMG evidence summaries, 26-Aug-2007
Interventions targeting practical medication management skills, administered to individuals or delivered over 12 weeks or more might possibly improve compliance on HAART for HIV/AIDS.
- Pegylated interferon for chronic hepatitis C
EBMG evidence summaries, 25-Oct-2006
Pegylated interferon alone or in combination with ribavirin in chronic hepatitis C results in sustained response more often than non-pegylated IFN treatment alone or combined with ribavirin.
- Pharmacological interventions for people with borderline personality disorder
EBMG evidence summaries, 7-Sep-2010
Antidepressants, antipsychotics and mood stabilisers might possibly have some positive effects in people with borderline personality disorder but there is no good quality evidence.
- Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus
EBMG evidence summaries, 25-Jan-2006
Fluoxetine, orlistat and sibutramine produce a modest short-term weight loss when used as a primary weight reduction strategy among adults with type 2 diabetes.
- Population-based interventions for reducing sexually transmitted infections including HIV
EBMG evidence summaries, 23-May-2012
Population-based interventions may have a limited effect on the prevalence of sexually transmitted infections (STI), but little effect on HIV incidence.
- Portal vein chemotherapy in colorectal cancer
EBMG evidence summaries, 23-Mar-2003
Portal vein infusion of 5-fluorouracil may produce an absolute improvement in 5-year survival of around 5%.
- Postoperative adjuvant chemotherapy in rectal cancer operated for cure
EBMG evidence summaries, 17-Apr-2012
Postoperative adjuvant chemotherapy appears to improve disease free survival (DFS) in patients with rectal carcinoma and no preoperative radiation. Available data do not define whether the efficacy of this treatment is highest in one specific TNM stage.
- Preoperative chemotherapy for women with operable breast cancer
EBMG evidence summaries, 22-Aug-2007
Preoperative chemotherapy increases breast conservation rates but does not affect the overall survival rates in women with operable breast cancer.
- Preoperative chemotherapy in esophageal carcinoma
EBMG evidence summaries, 3-Jun-2010
Preoperative chemotherapy may offer some advantage in survival compared to surgery alone for resectable thoracic esophageal cancer but the evidence is inconclusive.
- Pre-operative chemotherapy in non-small cell lung cancer
EBMG evidence summaries, 24-Oct-2007
Pre-operative chemotherapy may increase survival in patients with non-small cell lung cancer compared to surgery alone.
- Preoperative radiotherapy for rectal cancer
EBMG evidence summaries, 7-Apr-2007
Pre-operative radiotherapy followed by surgery is more effective than surgery alone for preventing local recurrence of rectal cancer, and may also improve survival.
- Preoperative radiotherapy in esophageal carcinoma
EBMG evidence summaries, 11-Aug-2003
Preoperative radiotherapy may offer some advantage in survival in esophageal carcinoma but the evidence is inconclusive, and the possible benefit would be only 3–4%.
- Preventing oral candidiasis in cancer patients
EBMG evidence summaries, 11-Mar-2010
Drugs absorbed or partially absorbed from the gastrointestinal (GI) tract prevent oral candidiasis in patients receiving treatment for cancer.
- Preventing skin cancer by reducing exposure to ultraviolet radiation
EBMG evidence summaries, 6-Apr-2007
Interventions to increase the use of protective clothing may be effective at least in primary school settings, and possibly in recreational settings.
